DSB says industry is ready to meet UPI mandate ahead of deadline

The Unique Product Identifier will be required for certain OTC derivatives in the EU at the end of April, following US adoption in January.

Early last week, the Derivatives Service Bureau (DSB)—the body in charge of two widely used over-the-counter derivative trade identifiers—released its assessment of industry readiness for the Unique Product Identifier, the first globally mandated OTC derivative identifier.

The EU is the second G20 jurisdiction to implement the UPI, following the US’ implementation in January. The requirement to use it is part of the EU’s European Market Infrastructure Regulation (Emir) Refit, which comes into

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here